Veterinary Infectious Disease Diagnostics Market by Product (Consumables, Instruments), Technology (Molecular Diagnostic, PCR, ELISA, Immunodiagnostics, Rapid Tests), Animal Type (Companion Animal, Livestock), End User & Region - Global Forecast to 2030
The veterinary infectious disease diagnostics market is expected to grow from USD 2.87 billion in 2025 to USD 4.22 billion by 2030, at a CAGR of 8.0%. This growth is driven by several important factors that reflect the changing landscape of animal health and disease management.
One primary driver is the increasing burden of infectious diseases among both companion animals and livestock, which has heightened the need for rapid, reliable, and field-deployable diagnostic solutions. The rise in outbreaks of diseases such as avian influenza, leptospirosis, and brucellosis is leading veterinarians and animal producers to prioritize early and accurate detection to mitigate risks.
Another significant factor is the shift towards preventive veterinary care. As awareness grows among pet owners and livestock handlers, there is a stronger emphasis on routine screenings and health monitoring to identify infections before they escalate. This trend is also supported by a growing recognition of the economic and public health consequences associated with the transmission of zoonotic diseases.
“By animal type, the companion animals segment is projected to grow at the highest CAGR during the forecast period.”
The companion animals segment is expected to see the highest growth in the veterinary infectious disease diagnostics market, driven by increasing pet ownership, especially in urban high-income households. Pet owners are more willing to invest in health check-ups and diagnostic services due to the growing awareness of zoonotic diseases and the importance of early detection. Additionally, innovations in point-of-care and home-based diagnostic tools enhance access for both pet owners and veterinarians. With more frequent visits to veterinary clinics and rising healthcare spending for pets, this segment is projected for rapid growth in the market.
“By technology, the immunodiagnostics segment accounted for the largest market share in 2024.”
In 2024, the immunodiagnostics segment dominated the veterinary infectious disease diagnostics market due to its cost-effectiveness and high accuracy. Techniques like ELISA and lateral flow assays are commonly used to detect various infectious diseases in companion and livestock animals. These tests provide rapid results, are user-friendly, and require minimal equipment, making them ideal for veterinary clinics and field use. Their ability to detect specific antigens or antibodies enables early diagnosis and effective disease management, making them valuable for large population screenings and routine surveillance programs.
“The Asia Pacific region is expected to witness the highest growth rate during the forecast period.”
The Asia Pacific is set to experience the highest growth in the veterinary infectious disease diagnostics market due to various demographic, economic, and healthcare factors. The region's large livestock population drives the demand for accurate diagnostics to address rising infectious diseases like foot-and-mouth disease and avian influenza. Additionally, the increasing number of companion animals, especially in urban areas of China and India, is boosting veterinary healthcare spending. Enhanced veterinary infrastructure, heightened awareness of zoonotic threats, and investments in animal health are also contributing to market growth. Companies are expanding their presence in the region to improve access to advanced diagnostic technologies.
Breakdown of supply-side primary interviews:
The market study covers the veterinary infectious disease diagnostics market in various segments. It aims to estimate the market size and growth potential of this market by product, technology, animal type, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their products and business offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report can assist established companies and newer or smaller firms in understanding market trends, enabling them to capture a larger market share. Firms that acquire the report can implement one or more of the five strategies outlined below.
This report provides insights into the following points:
One primary driver is the increasing burden of infectious diseases among both companion animals and livestock, which has heightened the need for rapid, reliable, and field-deployable diagnostic solutions. The rise in outbreaks of diseases such as avian influenza, leptospirosis, and brucellosis is leading veterinarians and animal producers to prioritize early and accurate detection to mitigate risks.
Another significant factor is the shift towards preventive veterinary care. As awareness grows among pet owners and livestock handlers, there is a stronger emphasis on routine screenings and health monitoring to identify infections before they escalate. This trend is also supported by a growing recognition of the economic and public health consequences associated with the transmission of zoonotic diseases.
“By animal type, the companion animals segment is projected to grow at the highest CAGR during the forecast period.”
The companion animals segment is expected to see the highest growth in the veterinary infectious disease diagnostics market, driven by increasing pet ownership, especially in urban high-income households. Pet owners are more willing to invest in health check-ups and diagnostic services due to the growing awareness of zoonotic diseases and the importance of early detection. Additionally, innovations in point-of-care and home-based diagnostic tools enhance access for both pet owners and veterinarians. With more frequent visits to veterinary clinics and rising healthcare spending for pets, this segment is projected for rapid growth in the market.
“By technology, the immunodiagnostics segment accounted for the largest market share in 2024.”
In 2024, the immunodiagnostics segment dominated the veterinary infectious disease diagnostics market due to its cost-effectiveness and high accuracy. Techniques like ELISA and lateral flow assays are commonly used to detect various infectious diseases in companion and livestock animals. These tests provide rapid results, are user-friendly, and require minimal equipment, making them ideal for veterinary clinics and field use. Their ability to detect specific antigens or antibodies enables early diagnosis and effective disease management, making them valuable for large population screenings and routine surveillance programs.
“The Asia Pacific region is expected to witness the highest growth rate during the forecast period.”
The Asia Pacific is set to experience the highest growth in the veterinary infectious disease diagnostics market due to various demographic, economic, and healthcare factors. The region's large livestock population drives the demand for accurate diagnostics to address rising infectious diseases like foot-and-mouth disease and avian influenza. Additionally, the increasing number of companion animals, especially in urban areas of China and India, is boosting veterinary healthcare spending. Enhanced veterinary infrastructure, heightened awareness of zoonotic threats, and investments in animal health are also contributing to market growth. Companies are expanding their presence in the region to improve access to advanced diagnostic technologies.
Breakdown of supply-side primary interviews:
- By Company Type: Tier 1 (45%), Tier 2 (20%), and Tier 3 (35%)
- By Designation: C-level Executives (35%), Directors (25%), and Other Designations (40%)
- By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and the Middle East & Africa (5%)
- By End User: Veterinary Reference Laboratories (40%), Veterinary Hospitals & Clinics (25%), POC/In-house Testing (20%), and Veterinary Research Institutes & Universities (15%)
- By Designation: Veterinary Healthcare Professionals (35%), Department Heads (27%), Procurement Heads (22%), and Other Designations (16%)
- By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and the Middle East & Africa (5%)
The market study covers the veterinary infectious disease diagnostics market in various segments. It aims to estimate the market size and growth potential of this market by product, technology, animal type, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their products and business offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report can assist established companies and newer or smaller firms in understanding market trends, enabling them to capture a larger market share. Firms that acquire the report can implement one or more of the five strategies outlined below.
This report provides insights into the following points:
- Analysis of key drivers (growth in companion animal population, increasing demand for animal-derived food products, growing concerns about infectious zoonotic diseases, rising demand for pet insurance and growing animal health expenditures, increasing number of veterinary practitioners and rising income levels in developed markets, and growing focus on disease control and prevention measures), restraints (rising pet care costs and high cost of veterinary diagnostic tests), opportunities (growth potential of emerging economies and integration of AI and ML), and challenges (low animal healthcare awareness in emerging countries and shortage of veterinary practitioners in emerging economies) influencing the growth of the veterinary infectious disease diagnostics market.
- Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the veterinary infectious disease diagnostics market.
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of veterinary infectious disease diagnostic products across regions.
- Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the veterinary infectious disease diagnostics market.
- Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the veterinary infectious disease diagnostics market.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.4 MARKET STAKEHOLDERS
1.5 LIMITATIONS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
2.2 RESEARCH METHODOLOGY DESIGN
2.2.1 SECONDARY RESEARCH
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY DATA
2.2.2.1 Key data from primary sources
2.2.2.2 Key industry insights
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.4 MARKET BREAKDOWN & DATA TRIANGULATION
2.5 MARKET SHARE ESTIMATION
2.6 RESEARCH ASSUMPTIONS
2.7 RISK ASSESSMENT
2.8 RESEARCH LIMITATIONS
2.8.1 METHODOLOGY-RELATED LIMITATIONS
2.8.2 SCOPE-RELATED LIMITATIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET OVERVIEW
4.2 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & COUNTRY (2024)
4.3 INFECTIOUS DISEASE DIAGNOSTICS MARKET: REGIONAL MIX
4.4 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.5 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: DEVELOPED VS. EMERGING ECONOMIES
5 MARKET OVERVIEW
5.1 MARKET DYNAMICS
5.1.1 DRIVERS
5.1.1.1 Growth in companion animal population
5.1.1.2 Increasing demand for animal-derived food products
5.1.1.3 Growing concerns about infectious zoonotic diseases
5.1.1.4 Rising demand for pet insurance and growing animal health expenditure
5.1.1.5 Increasing number of veterinary practitioners and rising income levels in developed markets
5.1.1.6 Growing focus on disease control & prevention measures
5.1.2 RESTRAINTS
5.1.2.1 Rising pet care costs
5.1.2.2 High cost of veterinary diagnostic tests
5.1.3 OPPORTUNITIES
5.1.3.1 Growth potential of emerging economies
5.1.3.2 Integration of AI & ML
5.1.4 CHALLENGES
5.1.4.1 Low animal healthcare awareness in emerging countries
5.1.4.2 Shortage of veterinary practitioners in emerging economies
5.2 INDUSTRY TRENDS
5.2.1 ADOPTION OF MULTIPLE TEST PANELS
5.2.2 OUTSOURCING OF VETERINARY DIAGNOSTIC TESTING SERVICES
5.2.3 GROWING SCALE OF VETERINARY BUSINESSES
5.3 TECHNOLOGY ANALYSIS
5.3.1 KEY TECHNOLOGIES
5.3.1.1 Portable instruments for POC diagnostic services
5.3.1.2 Biosensor-based diagnostic systems
5.3.2 ADJACENT TECHNOLOGIES
5.3.2.1 Wearable biosensors & remote monitoring devices
5.3.2.2 Rapid & sensitive veterinary diagnostic kits
5.3.2.3 Breath & saliva-based diagnostic tools
5.3.2.4 Microfluidics & Lab-on-a-chip devices
5.3.3 COMPLEMENTARY TECHNOLOGIES
5.3.3.1 AI-driven diagnostic platforms
5.3.3.2 Next-generation sequencing (NGS)
5.4 PORTER’S FIVE FORCES ANALYSIS
5.4.1 THREAT OF NEW ENTRANTS
5.4.2 THREAT OF SUBSTITUTES
5.4.3 BARGAINING POWER OF SUPPLIERS
5.4.4 BARGAINING POWER OF BUYERS
5.4.5 INTENSITY OF COMPETITIVE RIVALRY
5.5 REGULATORY ANALYSIS
5.5.1 REGULATORY LANDSCAPE
5.5.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.5.2.1 North America
5.5.2.2 Europe
5.5.2.3 Rest of the World
5.6 PATENT ANALYSIS
5.6.1 PATENT PUBLICATION TRENDS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS
5.6.2 JURISDICTION & TOP APPLICANT ANALYSIS
5.7 TRADE ANALYSIS
5.7.1 TRADE DATA FOR HS CODE 9018
5.7.1.1 Import data for HS Code 9018
5.7.1.2 Export data for HS Code 9018
5.8 PRICING ANALYSIS
5.8.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2022–2024
5.8.2 AVERAGE SELLING PRICE, BY REGION, 2022–2024
5.8.2.1 Average selling price of ELISA and PCR test kits, by region, 2024
5.8.2.2 Average selling price trend of ELISA test kits (per 96-well kit), by region, 2022–2024
5.8.2.3 Average selling price trend of lateral flow rapid tests (per unit), by region, 2022–2024
5.8.2.4 Average selling price trend of PCR test kits (veterinary panels), by region, 2022–2024
5.8.2.5 Average selling price trend of immunoassay analyzers (benchtop), by region, 2022–2024
5.8.2.6 Average selling price trend of high-end immunoassay analyzers, by region, 2022–2024
5.8.2.7 Average selling price trend of nucleic acid sequencers (benchtop), by region, 2022–2024
5.9 REIMBURSEMENT ANALYSIS
5.10 KEY CONFERENCES & EVENTS, 2025–2026
5.11 KEY STAKEHOLDERS & BUYING CRITERIA
5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.11.2 BUYING CRITERIA
5.12 END-USER PERSPECTIVE & UNMET NEEDS
5.13 IMPACT OF AI ON VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET
5.13.1 INTRODUCTION
5.13.2 MARKET POTENTIAL IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS ECOSYSTEM
5.13.3 AI USE CASES
5.13.4 KEY COMPANIES IMPLEMENTING AI IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS
5.14 ECOSYSTEM ANALYSIS
5.15 VALUE CHAIN ANALYSIS
5.16 SUPPLY CHAIN ANALYSIS
5.17 ADJACENT MARKET ANALYSIS
5.18 INVESTMENT & FUNDING SCENARIO
5.19 IMPACT OF 2025 US TARIFF ON VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET
5.19.1 INTRODUCTION
5.19.2 KEY TARIFF RATES
5.19.3 PRICE IMPACT ANALYSIS
5.19.4 IMPACT ON COUNTRY/REGION
5.19.5 IMPACT ON END-USE INDUSTRIES
6 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 CONSUMABLES
6.2.1 RECURRENT PURCHASE OF DIAGNOSTIC KITS AND REAGENTS TO BOOST MARKET GROWTH
6.3 INSTRUMENTS
6.3.1 INCREASING DEMAND FOR POC ANALYZERS TO SUPPORT MARKET GROWTH
7 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY
7.1 INTRODUCTION
7.2 IMMUNODIAGNOSTICS
7.2.1 LATERAL FLOW ASSAYS
7.2.1.1 Lateral flow rapid tests
7.2.1.1.1 Ability to provide real-time insights to drive market
7.2.1.2 Lateral flow strip readers
7.2.1.2.1 Rising need for readers to determine analyte quantity to fuel adoption
7.2.2 ELISA TESTS
7.2.2.1 Cost-effectiveness and ease of use to drive market
7.2.3 IMMUNOASSAY ANALYZERS
7.2.3.1 High sensitivity & specificity for biomarker detection to drive market
7.2.4 OTHER IMMUNODIAGNOSTIC TECHNOLOGIES
7.3 MOLECULAR DIAGNOSTICS
7.3.1 PCR TESTS
7.3.1.1 Increased laboratory usage in proteomics & genomics to support growth
7.3.2 NUCLEIC ACID SEQUENCING
7.3.2.1 Growing use of nucleic acid sequencing to identify pathogens to fuel market
7.3.3 MICROARRAYS
7.3.3.1 Growing applications of biochips in identifying infectious diseases to drive market
7.3.4 OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES
7.4 OTHER TECHNOLOGIES
8 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE
8.1 INTRODUCTION
8.2 COMPANION ANIMALS
8.2.1 COMPANION ANIMALS MARKET, BY ANIMAL TYPE
8.2.1.1 Dogs
8.2.1.1.1 High insurance coverage for dogs and rising disposable incomes to drive market
8.2.1.2 Cats
8.2.1.2.1 Growing pet cat population to support growth
8.2.1.3 Horses
8.2.1.3.1 Growing equine health awareness to drive market
8.2.1.4 Other companion animals
8.2.2 COMPANION ANIMALS MARKET, BY TECHNOLOGY
8.2.2.1 Immunodiagnostics
8.2.2.1.1 Lateral flow assays
8.2.2.1.1.1 Rapid results, no requirement for multiple sample batches, and ease of visual reading to drive market growth
8.2.2.1.2 ELISA tests
8.2.2.1.2.1 High sensitivity, specificity, and precision of ELISA tests to drive market
8.2.2.1.3 Immunoassay analyzers
8.2.2.1.3.1 Ability to process multiple samples to drive adoption of immunoassay analyzers
8.2.2.1.4 Other immunodiagnostic technologies
8.2.2.2 Molecular diagnostics
8.2.2.2.1 PCR tests
8.2.2.2.1.1 Extensive use of PCR due to its high specificity and sensitivity to boost adoption
8.2.2.2.2 Nucleic acid sequencing
8.2.2.2.2.1 Increasing use of nucleic acid sequencing for pathogen discovery and identification to support growth
8.2.2.2.3 Microarrays
8.2.2.2.3.1 Technological advancements and increasing incidence of infectious diseases to fuel demand for microarrays
8.2.2.2.4 Other molecular diagnostic technologies
8.2.2.3 Other technologies
8.3 LIVESTOCK
8.3.1 LIVESTOCK MARKET, BY ANIMAL TYPE
8.3.1.1 Cattle
8.3.1.1.1 Growing consumption of meat to support market growth
8.3.1.2 Pigs
8.3.1.2.1 Growing incidence of infectious diseases to drive market
8.3.1.3 Poultry
8.3.1.3.1 Increasing demand for poultry meat to contribute to market growth
8.3.1.4 Other livestock
8.3.2 LIVESTOCK MARKET, BY TECHNOLOGY
8.3.2.1 Immunodiagnostics
8.3.2.1.1 Lateral flow assays
8.3.2.1.1.1 Field-readiness and stakeholder accessibility of LFAs to boost demand
8.3.2.1.2 ELISA tests
8.3.2.1.2.1 Cost-effectiveness, high sensitivity, and ease of use to drive ELISA market
8.3.2.1.3 Immunoassay analyzers
8.3.2.1.3.1 High sensitivity & specificity for biomarker detection to drive market
8.3.2.1.4 Other immunodiagnostic technologies
8.3.2.2 Molecular diagnostics
8.3.2.2.1 PCR tests
8.3.2.2.1.1 Growing use of PCR in proteomics and genomics to drive market growth
8.3.2.2.2 Nucleic acid sequencing
8.3.2.2.2.1 Identification of pathogens to fuel market
8.3.2.2.3 Microarrays
8.3.2.2.3.1 Emergence of biochips and growing applications in identifying infectious diseases to drive growth
8.3.2.2.4 Other molecular diagnostic technologies
8.3.2.3 Other technologies
9 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER
9.1 INTRODUCTION
9.2 VETERINARY REFERENCE LABORATORIES
9.2.1 LARGE VOLUME OF TESTING SAMPLES AND AVAILABILITY OF SKILLED WORKFORCE TO PROPEL MARKET
9.3 VETERINARY HOSPITALS & CLINICS
9.3.1 GROWING PET OWNERSHIP AND SPENDING ON PET CARE TO DRIVE MARKET
9.4 POINT-OF-CARE/IN-HOUSE TESTING
9.4.1 COST-EFFECTIVENESS AND RAPID RESULTS TO BOOST DEMAND
9.5 VETERINARY RESEARCH INSTITUTES & UNIVERSITIES
9.5.1 INCREASING COLLABORATIONS BETWEEN PRIVATE COMPANIES AND RESEARCH INSTITUTES TO SUPPORT GROWTH
10 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
10.2.2 US
10.2.2.1 High veterinary healthcare expenditure to drive market
10.2.3 CANADA
10.2.3.1 Growing pet adoption to drive market
10.3 EUROPE
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
10.3.2 GERMANY
10.3.2.1 Rising awareness of zoonotic diseases to fuel market
10.3.3 UK
10.3.3.1 Increasing pet ownership to drive market
10.3.4 FRANCE
10.3.4.1 Willingness of pet owners to spend on pet health to drive market
10.3.5 ITALY
10.3.5.1 Growing consumption of meat & dairy products to drive market
10.3.6 SPAIN
10.3.6.1 Growing demand for poultry products to fuel market
10.3.7 NETHERLANDS
10.3.7.1 Developments in veterinary diagnostic products to support market growth
10.3.8 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
10.4.2 CHINA
10.4.2.1 Increasing incidence of zoonotic diseases to propel market
10.4.3 JAPAN
10.4.3.1 Increasing pet expenditure to support market growth
10.4.4 INDIA
10.4.4.1 Increasing demand for dairy products to drive market
10.4.5 AUSTRALIA
10.4.5.1 Rise in pet ownership to support market growth
10.4.6 SOUTH KOREA
10.4.6.1 Rising need for specialized veterinary services to drive market
10.4.7 NEW ZEALAND
10.4.7.1 Focus on pet insurance to aid market
10.4.8 VIETNAM
10.4.8.1 Growing focus on disease surveillance to drive market
10.4.9 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
10.5.2 BRAZIL
10.5.2.1 Growth in livestock industry to boost demand
10.5.3 MEXICO
10.5.3.1 Increasing focus on poultry-associated products to support market growth
10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
10.6.2 GCC COUNTRIES
10.6.2.1 Kingdom of Saudi Arabia (KSA)
10.6.2.1.1 Technological advancements in veterinary diagnostics to boost demand
10.6.2.2 United Arab Emirates (UAE)
10.6.2.2.1 Favorable government support for vet diagnostics to drive market
10.6.2.3 Rest of GCC Countries
10.6.3 REST OF MIDDLE EAST & AFRICA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGY/RIGHT TO WIN
11.3 REVENUE ANALYSIS, 2020–2024
11.4 MARKET SHARE ANALYSIS, 2024
11.4.1 MARKET SHARE ANALYSIS FOR COMPANION ANIMALS
11.4.2 MARKET SHARE ANALYSIS FOR LIVESTOCK
11.4.3 RANKING OF KEY MARKET PLAYERS
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
11.5.5.1 Company footprint
11.5.5.2 Region footprint
11.5.5.3 Product footprint
11.5.5.4 Technology footprint
11.5.5.5 Animal type footprint
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
11.6.1 PROGRESSIVE COMPANIES
11.6.2 RESPONSIVE COMPANIES
11.6.3 DYNAMIC COMPANIES
11.6.4 STARTING BLOCKS
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
11.6.5.1 Detailed list of key startups/SMEs
11.6.5.2 Competitive benchmarking of key startups
11.7 BRAND/PRODUCT COMPARISON
11.8 R&D EXPENDITURE OF KEY PLAYERS
11.9 COMPANY VALUATION & FINANCIAL METRICS
11.9.1 FINANCIAL METRICS
11.9.2 COMPANY VALUATION
11.10 COMPETITIVE SCENARIO
11.10.1 PRODUCT LAUNCHES & ENHANCEMENTS
11.10.2 DEALS
11.10.3 EXPANSIONS
11.10.4 OTHER DEVELOPMENTS
12 COMPANY PROFILES
12.1 KEY PLAYERS
12.1.1 IDEXX LABORATORIES, INC.
12.1.1.1 Business overview
12.1.1.2 Products & services offered
12.1.1.3 Recent developments
12.1.1.3.1 Product/Service launches & enhancements
12.1.1.4 MnM view
12.1.1.4.1 Key strengths
12.1.1.4.2 Strategic choices
12.1.1.4.3 Weaknesses & competitive threats
12.1.2 ZOETIS SERVICES LLC
12.1.2.1 Business overview
12.1.2.2 Products & services offered
12.1.2.3 Recent developments
12.1.2.3.1 Product enhancements
12.1.2.3.2 Deals
12.1.2.3.3 Expansions
12.1.2.4 MnM view
12.1.2.4.1 Key strengths
12.1.2.4.2 Strategic choices
12.1.2.4.3 Weaknesses & competitive threats
12.1.3 THERMO FISHER SCIENTIFIC INC.
12.1.3.1 Business overview
12.1.3.2 Products & services offered
12.1.3.3 MnM view
12.1.3.3.1 Key strengths
12.1.3.3.2 Strategic choices
12.1.3.3.3 Weaknesses & competitive threats
12.1.4 VIRBAC
12.1.4.1 Business overview
12.1.4.2 Products & services offered
12.1.4.3 Recent developments
12.1.4.3.1 Deals
12.1.4.3.2 Expansions
12.1.4.4 MnM view
12.1.4.4.1 Key strengths
12.1.4.4.2 Strategic choices
12.1.4.4.3 Weaknesses & competitive threats
12.1.5 BIOM?RIEUX
12.1.5.1 Business overview
12.1.5.2 Products & services offered
12.1.5.3 Recent developments
12.1.5.3.1 Product launches & approvals
12.1.5.4 MnM view
12.1.5.4.1 Key strengths
12.1.5.4.2 Strategic choices
12.1.5.4.3 Weaknesses & competitive threats
12.1.6 ANTECH DIAGNOSTICS, INC.
12.1.6.1 Business overview
12.1.6.2 Products & services offered
12.1.6.3 Recent developments
12.1.6.3.1 Product launches
12.1.6.3.2 Expansions
12.1.7 INNOVATIVE DIAGNOSTICS
12.1.7.1 Business overview
12.1.7.2 Products & services offered
12.1.8 NEOGEN CORPORATION
12.1.8.1 Business overview
12.1.8.2 Products & services offered
12.1.8.2.1 Other developments
12.1.9 INDICAL BIOSCIENCE GMBH
12.1.9.1 Business overview
12.1.9.2 Products & services offered
12.1.9.3 Recent developments
12.1.9.3.1 Product enhancements
12.1.10 AGROLABO S.P.A.
12.1.10.1 Business overview
12.1.10.2 Products & services offered
12.1.11 BIONOTE
12.1.11.1 Business overview
12.1.11.2 Products & services offered
12.1.11.3 Recent developments
12.1.11.4 Product launches
12.1.11.4.1 Deals
12.1.12 BIOGAL
12.1.12.1 Business overview
12.1.12.2 Products & services offered
12.1.13 BIOCHEK
12.1.13.1 Business overview
12.1.13.2 Products & services offered
12.1.13.3 Recent developments
12.1.13.3.1 Product launches
12.1.13.3.2 Deals
12.1.14 MEGACOR DIAGNOSTIK GMBH
12.1.14.1 Business overview
12.1.14.2 Products & services offered
12.1.14.3 Recent developments
12.1.14.3.1 Product launches & enhancements
12.1.15 BIO-RAD LABORATORIES, INC.
12.1.15.1 Business overview
12.1.15.2 Products & services offered
12.2 OTHER PLAYERS
12.2.1 FASSISI, GMBH
12.2.2 BIOTANGENTS LIMITED
12.2.3 SKYER, INC.
12.2.4 BIOPANDA REAGENTS LTD.
12.2.5 SHENZHEN BIOEASY BIOTECHNOLOGY, INC.
12.2.6 GOLD STANDARD DIAGNOSTICS
12.2.7 BIO-X DIAGNOSTICS S.A.
12.2.8 DEMEDITEC DIAGNOSTICS GMBH
12.2.9 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
12.2.10 BIOSTONE ANIMAL HEALTH
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 RELATED REPORTS
13.4 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.4 MARKET STAKEHOLDERS
1.5 LIMITATIONS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
2.2 RESEARCH METHODOLOGY DESIGN
2.2.1 SECONDARY RESEARCH
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY DATA
2.2.2.1 Key data from primary sources
2.2.2.2 Key industry insights
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.4 MARKET BREAKDOWN & DATA TRIANGULATION
2.5 MARKET SHARE ESTIMATION
2.6 RESEARCH ASSUMPTIONS
2.7 RISK ASSESSMENT
2.8 RESEARCH LIMITATIONS
2.8.1 METHODOLOGY-RELATED LIMITATIONS
2.8.2 SCOPE-RELATED LIMITATIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET OVERVIEW
4.2 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & COUNTRY (2024)
4.3 INFECTIOUS DISEASE DIAGNOSTICS MARKET: REGIONAL MIX
4.4 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.5 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: DEVELOPED VS. EMERGING ECONOMIES
5 MARKET OVERVIEW
5.1 MARKET DYNAMICS
5.1.1 DRIVERS
5.1.1.1 Growth in companion animal population
5.1.1.2 Increasing demand for animal-derived food products
5.1.1.3 Growing concerns about infectious zoonotic diseases
5.1.1.4 Rising demand for pet insurance and growing animal health expenditure
5.1.1.5 Increasing number of veterinary practitioners and rising income levels in developed markets
5.1.1.6 Growing focus on disease control & prevention measures
5.1.2 RESTRAINTS
5.1.2.1 Rising pet care costs
5.1.2.2 High cost of veterinary diagnostic tests
5.1.3 OPPORTUNITIES
5.1.3.1 Growth potential of emerging economies
5.1.3.2 Integration of AI & ML
5.1.4 CHALLENGES
5.1.4.1 Low animal healthcare awareness in emerging countries
5.1.4.2 Shortage of veterinary practitioners in emerging economies
5.2 INDUSTRY TRENDS
5.2.1 ADOPTION OF MULTIPLE TEST PANELS
5.2.2 OUTSOURCING OF VETERINARY DIAGNOSTIC TESTING SERVICES
5.2.3 GROWING SCALE OF VETERINARY BUSINESSES
5.3 TECHNOLOGY ANALYSIS
5.3.1 KEY TECHNOLOGIES
5.3.1.1 Portable instruments for POC diagnostic services
5.3.1.2 Biosensor-based diagnostic systems
5.3.2 ADJACENT TECHNOLOGIES
5.3.2.1 Wearable biosensors & remote monitoring devices
5.3.2.2 Rapid & sensitive veterinary diagnostic kits
5.3.2.3 Breath & saliva-based diagnostic tools
5.3.2.4 Microfluidics & Lab-on-a-chip devices
5.3.3 COMPLEMENTARY TECHNOLOGIES
5.3.3.1 AI-driven diagnostic platforms
5.3.3.2 Next-generation sequencing (NGS)
5.4 PORTER’S FIVE FORCES ANALYSIS
5.4.1 THREAT OF NEW ENTRANTS
5.4.2 THREAT OF SUBSTITUTES
5.4.3 BARGAINING POWER OF SUPPLIERS
5.4.4 BARGAINING POWER OF BUYERS
5.4.5 INTENSITY OF COMPETITIVE RIVALRY
5.5 REGULATORY ANALYSIS
5.5.1 REGULATORY LANDSCAPE
5.5.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.5.2.1 North America
5.5.2.2 Europe
5.5.2.3 Rest of the World
5.6 PATENT ANALYSIS
5.6.1 PATENT PUBLICATION TRENDS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS
5.6.2 JURISDICTION & TOP APPLICANT ANALYSIS
5.7 TRADE ANALYSIS
5.7.1 TRADE DATA FOR HS CODE 9018
5.7.1.1 Import data for HS Code 9018
5.7.1.2 Export data for HS Code 9018
5.8 PRICING ANALYSIS
5.8.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2022–2024
5.8.2 AVERAGE SELLING PRICE, BY REGION, 2022–2024
5.8.2.1 Average selling price of ELISA and PCR test kits, by region, 2024
5.8.2.2 Average selling price trend of ELISA test kits (per 96-well kit), by region, 2022–2024
5.8.2.3 Average selling price trend of lateral flow rapid tests (per unit), by region, 2022–2024
5.8.2.4 Average selling price trend of PCR test kits (veterinary panels), by region, 2022–2024
5.8.2.5 Average selling price trend of immunoassay analyzers (benchtop), by region, 2022–2024
5.8.2.6 Average selling price trend of high-end immunoassay analyzers, by region, 2022–2024
5.8.2.7 Average selling price trend of nucleic acid sequencers (benchtop), by region, 2022–2024
5.9 REIMBURSEMENT ANALYSIS
5.10 KEY CONFERENCES & EVENTS, 2025–2026
5.11 KEY STAKEHOLDERS & BUYING CRITERIA
5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.11.2 BUYING CRITERIA
5.12 END-USER PERSPECTIVE & UNMET NEEDS
5.13 IMPACT OF AI ON VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET
5.13.1 INTRODUCTION
5.13.2 MARKET POTENTIAL IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS ECOSYSTEM
5.13.3 AI USE CASES
5.13.4 KEY COMPANIES IMPLEMENTING AI IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS
5.14 ECOSYSTEM ANALYSIS
5.15 VALUE CHAIN ANALYSIS
5.16 SUPPLY CHAIN ANALYSIS
5.17 ADJACENT MARKET ANALYSIS
5.18 INVESTMENT & FUNDING SCENARIO
5.19 IMPACT OF 2025 US TARIFF ON VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET
5.19.1 INTRODUCTION
5.19.2 KEY TARIFF RATES
5.19.3 PRICE IMPACT ANALYSIS
5.19.4 IMPACT ON COUNTRY/REGION
5.19.5 IMPACT ON END-USE INDUSTRIES
6 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 CONSUMABLES
6.2.1 RECURRENT PURCHASE OF DIAGNOSTIC KITS AND REAGENTS TO BOOST MARKET GROWTH
6.3 INSTRUMENTS
6.3.1 INCREASING DEMAND FOR POC ANALYZERS TO SUPPORT MARKET GROWTH
7 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY
7.1 INTRODUCTION
7.2 IMMUNODIAGNOSTICS
7.2.1 LATERAL FLOW ASSAYS
7.2.1.1 Lateral flow rapid tests
7.2.1.1.1 Ability to provide real-time insights to drive market
7.2.1.2 Lateral flow strip readers
7.2.1.2.1 Rising need for readers to determine analyte quantity to fuel adoption
7.2.2 ELISA TESTS
7.2.2.1 Cost-effectiveness and ease of use to drive market
7.2.3 IMMUNOASSAY ANALYZERS
7.2.3.1 High sensitivity & specificity for biomarker detection to drive market
7.2.4 OTHER IMMUNODIAGNOSTIC TECHNOLOGIES
7.3 MOLECULAR DIAGNOSTICS
7.3.1 PCR TESTS
7.3.1.1 Increased laboratory usage in proteomics & genomics to support growth
7.3.2 NUCLEIC ACID SEQUENCING
7.3.2.1 Growing use of nucleic acid sequencing to identify pathogens to fuel market
7.3.3 MICROARRAYS
7.3.3.1 Growing applications of biochips in identifying infectious diseases to drive market
7.3.4 OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES
7.4 OTHER TECHNOLOGIES
8 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE
8.1 INTRODUCTION
8.2 COMPANION ANIMALS
8.2.1 COMPANION ANIMALS MARKET, BY ANIMAL TYPE
8.2.1.1 Dogs
8.2.1.1.1 High insurance coverage for dogs and rising disposable incomes to drive market
8.2.1.2 Cats
8.2.1.2.1 Growing pet cat population to support growth
8.2.1.3 Horses
8.2.1.3.1 Growing equine health awareness to drive market
8.2.1.4 Other companion animals
8.2.2 COMPANION ANIMALS MARKET, BY TECHNOLOGY
8.2.2.1 Immunodiagnostics
8.2.2.1.1 Lateral flow assays
8.2.2.1.1.1 Rapid results, no requirement for multiple sample batches, and ease of visual reading to drive market growth
8.2.2.1.2 ELISA tests
8.2.2.1.2.1 High sensitivity, specificity, and precision of ELISA tests to drive market
8.2.2.1.3 Immunoassay analyzers
8.2.2.1.3.1 Ability to process multiple samples to drive adoption of immunoassay analyzers
8.2.2.1.4 Other immunodiagnostic technologies
8.2.2.2 Molecular diagnostics
8.2.2.2.1 PCR tests
8.2.2.2.1.1 Extensive use of PCR due to its high specificity and sensitivity to boost adoption
8.2.2.2.2 Nucleic acid sequencing
8.2.2.2.2.1 Increasing use of nucleic acid sequencing for pathogen discovery and identification to support growth
8.2.2.2.3 Microarrays
8.2.2.2.3.1 Technological advancements and increasing incidence of infectious diseases to fuel demand for microarrays
8.2.2.2.4 Other molecular diagnostic technologies
8.2.2.3 Other technologies
8.3 LIVESTOCK
8.3.1 LIVESTOCK MARKET, BY ANIMAL TYPE
8.3.1.1 Cattle
8.3.1.1.1 Growing consumption of meat to support market growth
8.3.1.2 Pigs
8.3.1.2.1 Growing incidence of infectious diseases to drive market
8.3.1.3 Poultry
8.3.1.3.1 Increasing demand for poultry meat to contribute to market growth
8.3.1.4 Other livestock
8.3.2 LIVESTOCK MARKET, BY TECHNOLOGY
8.3.2.1 Immunodiagnostics
8.3.2.1.1 Lateral flow assays
8.3.2.1.1.1 Field-readiness and stakeholder accessibility of LFAs to boost demand
8.3.2.1.2 ELISA tests
8.3.2.1.2.1 Cost-effectiveness, high sensitivity, and ease of use to drive ELISA market
8.3.2.1.3 Immunoassay analyzers
8.3.2.1.3.1 High sensitivity & specificity for biomarker detection to drive market
8.3.2.1.4 Other immunodiagnostic technologies
8.3.2.2 Molecular diagnostics
8.3.2.2.1 PCR tests
8.3.2.2.1.1 Growing use of PCR in proteomics and genomics to drive market growth
8.3.2.2.2 Nucleic acid sequencing
8.3.2.2.2.1 Identification of pathogens to fuel market
8.3.2.2.3 Microarrays
8.3.2.2.3.1 Emergence of biochips and growing applications in identifying infectious diseases to drive growth
8.3.2.2.4 Other molecular diagnostic technologies
8.3.2.3 Other technologies
9 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER
9.1 INTRODUCTION
9.2 VETERINARY REFERENCE LABORATORIES
9.2.1 LARGE VOLUME OF TESTING SAMPLES AND AVAILABILITY OF SKILLED WORKFORCE TO PROPEL MARKET
9.3 VETERINARY HOSPITALS & CLINICS
9.3.1 GROWING PET OWNERSHIP AND SPENDING ON PET CARE TO DRIVE MARKET
9.4 POINT-OF-CARE/IN-HOUSE TESTING
9.4.1 COST-EFFECTIVENESS AND RAPID RESULTS TO BOOST DEMAND
9.5 VETERINARY RESEARCH INSTITUTES & UNIVERSITIES
9.5.1 INCREASING COLLABORATIONS BETWEEN PRIVATE COMPANIES AND RESEARCH INSTITUTES TO SUPPORT GROWTH
10 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
10.2.2 US
10.2.2.1 High veterinary healthcare expenditure to drive market
10.2.3 CANADA
10.2.3.1 Growing pet adoption to drive market
10.3 EUROPE
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
10.3.2 GERMANY
10.3.2.1 Rising awareness of zoonotic diseases to fuel market
10.3.3 UK
10.3.3.1 Increasing pet ownership to drive market
10.3.4 FRANCE
10.3.4.1 Willingness of pet owners to spend on pet health to drive market
10.3.5 ITALY
10.3.5.1 Growing consumption of meat & dairy products to drive market
10.3.6 SPAIN
10.3.6.1 Growing demand for poultry products to fuel market
10.3.7 NETHERLANDS
10.3.7.1 Developments in veterinary diagnostic products to support market growth
10.3.8 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
10.4.2 CHINA
10.4.2.1 Increasing incidence of zoonotic diseases to propel market
10.4.3 JAPAN
10.4.3.1 Increasing pet expenditure to support market growth
10.4.4 INDIA
10.4.4.1 Increasing demand for dairy products to drive market
10.4.5 AUSTRALIA
10.4.5.1 Rise in pet ownership to support market growth
10.4.6 SOUTH KOREA
10.4.6.1 Rising need for specialized veterinary services to drive market
10.4.7 NEW ZEALAND
10.4.7.1 Focus on pet insurance to aid market
10.4.8 VIETNAM
10.4.8.1 Growing focus on disease surveillance to drive market
10.4.9 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
10.5.2 BRAZIL
10.5.2.1 Growth in livestock industry to boost demand
10.5.3 MEXICO
10.5.3.1 Increasing focus on poultry-associated products to support market growth
10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
10.6.2 GCC COUNTRIES
10.6.2.1 Kingdom of Saudi Arabia (KSA)
10.6.2.1.1 Technological advancements in veterinary diagnostics to boost demand
10.6.2.2 United Arab Emirates (UAE)
10.6.2.2.1 Favorable government support for vet diagnostics to drive market
10.6.2.3 Rest of GCC Countries
10.6.3 REST OF MIDDLE EAST & AFRICA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGY/RIGHT TO WIN
11.3 REVENUE ANALYSIS, 2020–2024
11.4 MARKET SHARE ANALYSIS, 2024
11.4.1 MARKET SHARE ANALYSIS FOR COMPANION ANIMALS
11.4.2 MARKET SHARE ANALYSIS FOR LIVESTOCK
11.4.3 RANKING OF KEY MARKET PLAYERS
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
11.5.5.1 Company footprint
11.5.5.2 Region footprint
11.5.5.3 Product footprint
11.5.5.4 Technology footprint
11.5.5.5 Animal type footprint
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
11.6.1 PROGRESSIVE COMPANIES
11.6.2 RESPONSIVE COMPANIES
11.6.3 DYNAMIC COMPANIES
11.6.4 STARTING BLOCKS
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
11.6.5.1 Detailed list of key startups/SMEs
11.6.5.2 Competitive benchmarking of key startups
11.7 BRAND/PRODUCT COMPARISON
11.8 R&D EXPENDITURE OF KEY PLAYERS
11.9 COMPANY VALUATION & FINANCIAL METRICS
11.9.1 FINANCIAL METRICS
11.9.2 COMPANY VALUATION
11.10 COMPETITIVE SCENARIO
11.10.1 PRODUCT LAUNCHES & ENHANCEMENTS
11.10.2 DEALS
11.10.3 EXPANSIONS
11.10.4 OTHER DEVELOPMENTS
12 COMPANY PROFILES
12.1 KEY PLAYERS
12.1.1 IDEXX LABORATORIES, INC.
12.1.1.1 Business overview
12.1.1.2 Products & services offered
12.1.1.3 Recent developments
12.1.1.3.1 Product/Service launches & enhancements
12.1.1.4 MnM view
12.1.1.4.1 Key strengths
12.1.1.4.2 Strategic choices
12.1.1.4.3 Weaknesses & competitive threats
12.1.2 ZOETIS SERVICES LLC
12.1.2.1 Business overview
12.1.2.2 Products & services offered
12.1.2.3 Recent developments
12.1.2.3.1 Product enhancements
12.1.2.3.2 Deals
12.1.2.3.3 Expansions
12.1.2.4 MnM view
12.1.2.4.1 Key strengths
12.1.2.4.2 Strategic choices
12.1.2.4.3 Weaknesses & competitive threats
12.1.3 THERMO FISHER SCIENTIFIC INC.
12.1.3.1 Business overview
12.1.3.2 Products & services offered
12.1.3.3 MnM view
12.1.3.3.1 Key strengths
12.1.3.3.2 Strategic choices
12.1.3.3.3 Weaknesses & competitive threats
12.1.4 VIRBAC
12.1.4.1 Business overview
12.1.4.2 Products & services offered
12.1.4.3 Recent developments
12.1.4.3.1 Deals
12.1.4.3.2 Expansions
12.1.4.4 MnM view
12.1.4.4.1 Key strengths
12.1.4.4.2 Strategic choices
12.1.4.4.3 Weaknesses & competitive threats
12.1.5 BIOM?RIEUX
12.1.5.1 Business overview
12.1.5.2 Products & services offered
12.1.5.3 Recent developments
12.1.5.3.1 Product launches & approvals
12.1.5.4 MnM view
12.1.5.4.1 Key strengths
12.1.5.4.2 Strategic choices
12.1.5.4.3 Weaknesses & competitive threats
12.1.6 ANTECH DIAGNOSTICS, INC.
12.1.6.1 Business overview
12.1.6.2 Products & services offered
12.1.6.3 Recent developments
12.1.6.3.1 Product launches
12.1.6.3.2 Expansions
12.1.7 INNOVATIVE DIAGNOSTICS
12.1.7.1 Business overview
12.1.7.2 Products & services offered
12.1.8 NEOGEN CORPORATION
12.1.8.1 Business overview
12.1.8.2 Products & services offered
12.1.8.2.1 Other developments
12.1.9 INDICAL BIOSCIENCE GMBH
12.1.9.1 Business overview
12.1.9.2 Products & services offered
12.1.9.3 Recent developments
12.1.9.3.1 Product enhancements
12.1.10 AGROLABO S.P.A.
12.1.10.1 Business overview
12.1.10.2 Products & services offered
12.1.11 BIONOTE
12.1.11.1 Business overview
12.1.11.2 Products & services offered
12.1.11.3 Recent developments
12.1.11.4 Product launches
12.1.11.4.1 Deals
12.1.12 BIOGAL
12.1.12.1 Business overview
12.1.12.2 Products & services offered
12.1.13 BIOCHEK
12.1.13.1 Business overview
12.1.13.2 Products & services offered
12.1.13.3 Recent developments
12.1.13.3.1 Product launches
12.1.13.3.2 Deals
12.1.14 MEGACOR DIAGNOSTIK GMBH
12.1.14.1 Business overview
12.1.14.2 Products & services offered
12.1.14.3 Recent developments
12.1.14.3.1 Product launches & enhancements
12.1.15 BIO-RAD LABORATORIES, INC.
12.1.15.1 Business overview
12.1.15.2 Products & services offered
12.2 OTHER PLAYERS
12.2.1 FASSISI, GMBH
12.2.2 BIOTANGENTS LIMITED
12.2.3 SKYER, INC.
12.2.4 BIOPANDA REAGENTS LTD.
12.2.5 SHENZHEN BIOEASY BIOTECHNOLOGY, INC.
12.2.6 GOLD STANDARD DIAGNOSTICS
12.2.7 BIO-X DIAGNOSTICS S.A.
12.2.8 DEMEDITEC DIAGNOSTICS GMBH
12.2.9 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
12.2.10 BIOSTONE ANIMAL HEALTH
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 RELATED REPORTS
13.4 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 STANDARD CURRENCY CONVERSION RATES (USD)
TABLE 2 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: ASSUMPTIONS ANALYSIS
TABLE 3 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: RISK ASSESSMENT ANALYSIS
TABLE 4 NUMBER OF US HOUSEHOLDS THAT OWN A PET IN 2024, BY ANIMAL TYPE (MILLIONS)
TABLE 5 ANIMAL DISEASE OUTBREAKS IN ASIA PACIFIC COUNTRIES (2009–2023)
TABLE 6 AVERAGE PREMIUMS PAID IN US, 2020 VS. 2023
TABLE 7 NORTH AMERICA: PET HEALTH INSURANCE MARKET (2012–2023) (USD MILLION)
TABLE 8 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 9 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: MAJOR PATENTS
TABLE 13 IMPORT DATA FOR HS CODE 9018, BY COUNTRY, 2020–2023 (USD THOUSAND)
TABLE 14 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2020–2023 (USD THOUSAND)
TABLE 15 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2022–2024
TABLE 16 AVERAGE SELLING PRICE TREND OF ELISA TEST KITS (PER 96-WELL KIT), BY REGION, 2022–2024
TABLE 17 AVERAGE SELLING PRICE TREND OF LATERAL FLOW RAPID TESTS (PER UNIT), BY REGION, 2022–2024
TABLE 18 AVERAGE SELLING PRICE TREND OF PCR TEST KITS (VETERINARY PANELS), BY REGION, 2022–2024
TABLE 19 AVERAGE SELLING PRICE TREND OF IMMUNOASSAY ANALYZER (BENCHTOP), BY REGION, 2022–2024
TABLE 20 AVERAGE SELLING PRICE TREND OF HIGH-END IMMUNOASSAY ANALYZERS, BY REGION, 2022–2024
TABLE 21 AVERAGE SELLING PRICE TREND OF NUCLEIC ACID SEQUENCERS (BENCHTOP) BY REGION, 2022–2024
TABLE 22 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: KEY CONFERENCES & EVENTS, 2025–2026
TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTIC PRODUCTS (%)
TABLE 24 KEY BUYING CRITERIA FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTIC PRODUCTS
TABLE 25 KEY COMPANIES IMPLEMENTING AI IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS
TABLE 26 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: ROLE OF COMPANIES IN ECOSYSTEM
TABLE 27 US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 28 KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTIC PRODUCTS
TABLE 29 NORTH AMERICA: IMPACT ON CANADA DUE TO US TARIFFS
TABLE 30 EUROPE: IMPACT ON GERMANY AND UK DUE TO US TARIFFS
TABLE 31 ASIA PACIFIC: IMPACT ON CHINA, JAPAN, AND INDIA DUE TO US TARIFFS
TABLE 32 LATIN AMERICA: IMPACT ON MEXICO DUE TO US TARIFFS
TABLE 33 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 34 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 35 KEY PLAYERS OFFERING VETERINARY INFECTIOUS DISEASE DIAGNOSTIC CONSUMABLES
TABLE 36 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 37 KEY PLAYERS PROVIDING VETERINARY INFECTIOUS DISEASE DIAGNOSTIC INSTRUMENTS
TABLE 38 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 39 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 40 KEY PLAYERS PROVIDING IMMUNODIAGNOSTIC TECHNOLOGIES
TABLE 41 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 42 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 43 KEY PLAYERS PROVIDING LATERAL FLOW ASSAYS
TABLE 44 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY REGION, 2023–2030 (THOUSAND UNITS)
TABLE 45 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 46 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 47 KEY PLAYERS PROVIDING LATERAL FLOW RAPID TESTS
TABLE 48 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW RAPID TESTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 49 KEY PLAYERS PROVIDING LATERAL FLOW STRIP READERS
TABLE 50 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW STRIP READERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 51 KEY PLAYERS PROVIDING ELISA TESTS
TABLE 52 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR ELISA TESTS, BY REGION, 2023–2030 (THOUSAND UNITS)
TABLE 53 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR ELISA TESTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 54 KEY PLAYERS PROVIDING IMMUNOASSAY ANALYZERS
TABLE 55 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNOASSAY ANALYZERS, BY REGION, 2023–2030 (THOUSAND UNITS)
TABLE 56 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNOASSAY ANALYZERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 57 KEY PLAYERS PROVIDING OTHER IMMUNODIAGNOSTIC TECHNOLOGIES
TABLE 58 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER IMMUNODIAGNOSTIC TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 59 KEY PLAYERS PROVIDING MOLECULAR DIAGNOSTIC TESTS
TABLE 60 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 61 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 62 KEY PLAYERS PROVIDING PCR TESTS
TABLE 63 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR PCR TESTS, BY REGION, 2023–2030 (THOUSAND UNITS)
TABLE 64 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR PCR TESTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 65 KEY PLAYERS PROVIDING NUCLEIC ACID SEQUENCING
TABLE 66 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR NUCLEIC ACID SEQUENCING, BY REGION, 2023–2030 (THOUSAND UNITS)
TABLE 67 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR NUCLEIC ACID SEQUENCING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 68 KEY PLAYERS PROVIDING MICROARRAYS
TABLE 69 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MICROARRAYS, BY REGION, 2023–2030 (THOUSAND UNITS)
TABLE 70 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MICROARRAYS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 71 KEY PLAYERS PROVIDING OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES
TABLE 72 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 73 KEY PLAYERS PROVIDING OTHER TECHNOLOGIES
TABLE 74 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 75 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 76 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR COMPANION ANIMALS
TABLE 77 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 78 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 79 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR DOGS
TABLE 80 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR DOGS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 81 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR CATS
TABLE 82 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR CATS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 83 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR HORSES
TABLE 84 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR HORSES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 85 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR OTHER COMPANION ANIMALS
TABLE 86 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 87 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 88 KEY PLAYERS PROVIDING IMMUNODIAGNOSTIC TECHNOLOGIES FOR COMPANION ANIMALS
TABLE 89 COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 90 COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 91 KEY PLAYERS PROVIDING LATERAL FLOW ASSAYS FOR COMPANION ANIMALS
TABLE 92 COMPANION ANIMALS MARKET FOR LATERAL FLOW ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 93 KEY PLAYERS PROVIDING ELISA TESTS FOR COMPANION ANIMALS
TABLE 94 COMPANION ANIMALS MARKET FOR ELISA TESTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 95 KEY PLAYERS PROVIDING IMMUNOASSAY ANALYZERS FOR COMPANION ANIMALS
TABLE 96 COMPANION ANIMALS MARKET FOR IMMUNOASSAY ANALYZERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 97 KEY PLAYERS PROVIDING OTHER IMMUNODIAGNOSTIC TECHNOLOGIES FOR COMPANION ANIMALS
TABLE 98 COMPANION ANIMALS MARKET FOR OTHER IMMUNODIAGNOSTIC TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 99 KEY PLAYERS PROVIDING MOLECULAR DIAGNOSTICS FOR COMPANION ANIMALS
TABLE 100 COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 101 COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 102 KEY PLAYERS PROVIDING PCR TESTS FOR COMPANION ANIMALS
TABLE 103 COMPANION ANIMALS MARKET FOR PCR TESTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 104 KEY PLAYERS PROVIDING NUCLEIC ACID SEQUENCING FOR COMPANION ANIMALS
TABLE 105 COMPANION ANIMALS MARKET FOR NUCLEIC ACID SEQUENCING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 106 KEY PLAYERS PROVIDING MICROARRAYS FOR COMPANION ANIMALS
TABLE 107 COMPANION ANIMALS MARKET FOR MICROARRAYS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 108 KEY PLAYERS PROVIDING OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES FOR COMPANION ANIMALS
TABLE 109 COMPANION ANIMALS MARKET FOR OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 110 KEY PLAYERS PROVIDING OTHER TECHNOLOGIES FOR COMPANION ANIMALS
TABLE 111 COMPANION ANIMALS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 112 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR LIVESTOCK
TABLE 113 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 114 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 115 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR CATTLE
TABLE 116 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR CATTLE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 117 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR PIGS
TABLE 118 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR PIGS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 119 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR POULTRY
TABLE 120 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR POULTRY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 121 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR OTHER LIVESTOCK ANIMALS
TABLE 122 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER LIVESTOCK, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 123 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 124 KEY PLAYERS PROVIDING IMMUNODIAGNOSTIC TECHNOLOGIES FOR LIVESTOCK
TABLE 125 LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 126 LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 127 KEY PLAYERS PROVIDING LATERAL FLOW ASSAYS FOR LIVESTOCK
TABLE 128 LIVESTOCK MARKET FOR LATERAL FLOW ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 129 KEY PLAYERS PROVIDING ELISA TESTS FOR LIVESTOCK
TABLE 130 LIVESTOCK MARKET FOR ELISA TESTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 131 KEY PLAYERS PROVIDING IMMUNOASSAY ANALYZERS FOR LIVESTOCK
TABLE 132 LIVESTOCK MARKET FOR IMMUNOASSAY ANALYZERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 133 KEY PLAYERS PROVIDING OTHER IMMUNODIAGNOSTIC TECHNOLOGIES FOR LIVESTOCK
TABLE 134 LIVESTOCK MARKET FOR OTHER IMMUNODIAGNOSTIC TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 135 KEY PLAYERS PROVIDING MOLECULAR DIAGNOSTICS FOR LIVESTOCK
TABLE 136 LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 137 LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 138 KEY PLAYERS PROVIDING PCR TESTS FOR LIVESTOCK
TABLE 139 LIVESTOCK MARKET FOR PCR TESTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 140 KEY PLAYERS PROVIDING NUCLEIC ACID SEQUENCING FOR LIVESTOCK
TABLE 141 LIVESTOCK MARKET FOR NUCLEIC ACID SEQUENCING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 142 KEY PLAYERS PROVIDING MICROARRAYS FOR LIVESTOCK
TABLE 143 LIVESTOCK MARKET FOR MICROARRAYS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 144 KEY PLAYERS PROVIDING OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES FOR LIVESTOCK
TABLE 145 LIVESTOCK MARKET FOR OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 146 KEY PLAYERS PROVIDING OTHER TECHNOLOGIES FOR LIVESTOCK
TABLE 147 LIVESTOCK MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 148 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 149 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR VETERINARY REFERENCE LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 150 BASIC ANNUAL EXPENSES FOR CATS & DOGS IN US, 2023 (USD)
TABLE 151 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 152 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR POC/IN-HOUSE TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 153 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR VETERINARY RESEARCH INSTITUTES & UNIVERSITIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 154 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 155 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 156 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 157 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 158 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 159 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 160 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 161 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 162 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 163 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 164 NORTH AMERICA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 165 NORTH AMERICA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 166 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 167 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 168 NORTH AMERICA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 169 NORTH AMERICA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 170 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 171 US: KEY MACROINDICATORS
TABLE 172 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 173 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 174 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 175 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 176 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 177 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 178 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 179 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 180 US: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 181 US: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 182 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 183 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 184 US: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 185 US: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 186 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 187 CANADA: KEY MACROINDICATORS
TABLE 188 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 189 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 190 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 191 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 192 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 193 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 194 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 195 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 196 CANADA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 197 CANADA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 198 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 199 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 200 CANADA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 201 CANADA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 202 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 203 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 204 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 205 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 206 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 207 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 208 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 209 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 210 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 211 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 212 EUROPE: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 213 EUROPE: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 214 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 215 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 216 EUROPE: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 217 EUROPE: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 218 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 219 GERMANY: KEY MACROINDICATORS
TABLE 220 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 221 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 222 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 223 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 224 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 225 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 226 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 227 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 228 GERMANY: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 229 GERMANY: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 230 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 231 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 232 GERMANY: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 233 GERMANY: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 234 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 235 UK: KEY MACROINDICATORS
TABLE 236 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 237 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 238 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 239 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 240 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 241 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 242 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 243 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 244 UK: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 245 UK: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 246 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 247 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 248 UK: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 249 UK: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 250 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 251 FRANCE: KEY MACROINDICATORS
TABLE 252 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 253 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 254 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 255 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 256 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 257 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 258 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 259 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 260 FRANCE: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 261 FRANCE: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 262 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 263 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 264 FRANCE: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 265 FRANCE: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 266 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 267 ITALY: KEY MACROINDICATORS
TABLE 268 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 269 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 270 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 271 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 272 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 273 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 274 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 275 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 276 ITALY: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 277 ITALY: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 278 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 279 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 280 ITALY: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 281 ITALY: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 282 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 283 SPAIN: KEY MACROINDICATORS
TABLE 284 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 285 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 286 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 287 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 288 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 289 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 290 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 291 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 292 SPAIN: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 293 SPAIN: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 294 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 295 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 296 SPAIN: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 297 SPAIN: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 298 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 299 NETHERLANDS: KEY MACROINDICATORS
TABLE 300 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 301 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 302 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 303 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 304 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 305 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 306 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 307 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 308 NETHERLANDS: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 309 NETHERLANDS: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 310 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 311 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 312 NETHERLANDS: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 313 NETHERLANDS: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 314 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 315 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 316 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 317 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 318 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 319 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 320 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 321 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 322 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 323 REST OF EUROPE: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 324 REST OF EUROPE: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 325 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 326 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 327 REST OF EUROPE: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 328 REST OF EUROPE: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TAB
TABLE 1 STANDARD CURRENCY CONVERSION RATES (USD)
TABLE 2 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: ASSUMPTIONS ANALYSIS
TABLE 3 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: RISK ASSESSMENT ANALYSIS
TABLE 4 NUMBER OF US HOUSEHOLDS THAT OWN A PET IN 2024, BY ANIMAL TYPE (MILLIONS)
TABLE 5 ANIMAL DISEASE OUTBREAKS IN ASIA PACIFIC COUNTRIES (2009–2023)
TABLE 6 AVERAGE PREMIUMS PAID IN US, 2020 VS. 2023
TABLE 7 NORTH AMERICA: PET HEALTH INSURANCE MARKET (2012–2023) (USD MILLION)
TABLE 8 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 9 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: MAJOR PATENTS
TABLE 13 IMPORT DATA FOR HS CODE 9018, BY COUNTRY, 2020–2023 (USD THOUSAND)
TABLE 14 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2020–2023 (USD THOUSAND)
TABLE 15 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2022–2024
TABLE 16 AVERAGE SELLING PRICE TREND OF ELISA TEST KITS (PER 96-WELL KIT), BY REGION, 2022–2024
TABLE 17 AVERAGE SELLING PRICE TREND OF LATERAL FLOW RAPID TESTS (PER UNIT), BY REGION, 2022–2024
TABLE 18 AVERAGE SELLING PRICE TREND OF PCR TEST KITS (VETERINARY PANELS), BY REGION, 2022–2024
TABLE 19 AVERAGE SELLING PRICE TREND OF IMMUNOASSAY ANALYZER (BENCHTOP), BY REGION, 2022–2024
TABLE 20 AVERAGE SELLING PRICE TREND OF HIGH-END IMMUNOASSAY ANALYZERS, BY REGION, 2022–2024
TABLE 21 AVERAGE SELLING PRICE TREND OF NUCLEIC ACID SEQUENCERS (BENCHTOP) BY REGION, 2022–2024
TABLE 22 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: KEY CONFERENCES & EVENTS, 2025–2026
TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTIC PRODUCTS (%)
TABLE 24 KEY BUYING CRITERIA FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTIC PRODUCTS
TABLE 25 KEY COMPANIES IMPLEMENTING AI IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS
TABLE 26 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: ROLE OF COMPANIES IN ECOSYSTEM
TABLE 27 US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 28 KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTIC PRODUCTS
TABLE 29 NORTH AMERICA: IMPACT ON CANADA DUE TO US TARIFFS
TABLE 30 EUROPE: IMPACT ON GERMANY AND UK DUE TO US TARIFFS
TABLE 31 ASIA PACIFIC: IMPACT ON CHINA, JAPAN, AND INDIA DUE TO US TARIFFS
TABLE 32 LATIN AMERICA: IMPACT ON MEXICO DUE TO US TARIFFS
TABLE 33 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 34 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 35 KEY PLAYERS OFFERING VETERINARY INFECTIOUS DISEASE DIAGNOSTIC CONSUMABLES
TABLE 36 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 37 KEY PLAYERS PROVIDING VETERINARY INFECTIOUS DISEASE DIAGNOSTIC INSTRUMENTS
TABLE 38 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 39 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 40 KEY PLAYERS PROVIDING IMMUNODIAGNOSTIC TECHNOLOGIES
TABLE 41 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 42 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 43 KEY PLAYERS PROVIDING LATERAL FLOW ASSAYS
TABLE 44 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY REGION, 2023–2030 (THOUSAND UNITS)
TABLE 45 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 46 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 47 KEY PLAYERS PROVIDING LATERAL FLOW RAPID TESTS
TABLE 48 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW RAPID TESTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 49 KEY PLAYERS PROVIDING LATERAL FLOW STRIP READERS
TABLE 50 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW STRIP READERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 51 KEY PLAYERS PROVIDING ELISA TESTS
TABLE 52 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR ELISA TESTS, BY REGION, 2023–2030 (THOUSAND UNITS)
TABLE 53 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR ELISA TESTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 54 KEY PLAYERS PROVIDING IMMUNOASSAY ANALYZERS
TABLE 55 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNOASSAY ANALYZERS, BY REGION, 2023–2030 (THOUSAND UNITS)
TABLE 56 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNOASSAY ANALYZERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 57 KEY PLAYERS PROVIDING OTHER IMMUNODIAGNOSTIC TECHNOLOGIES
TABLE 58 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER IMMUNODIAGNOSTIC TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 59 KEY PLAYERS PROVIDING MOLECULAR DIAGNOSTIC TESTS
TABLE 60 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 61 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 62 KEY PLAYERS PROVIDING PCR TESTS
TABLE 63 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR PCR TESTS, BY REGION, 2023–2030 (THOUSAND UNITS)
TABLE 64 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR PCR TESTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 65 KEY PLAYERS PROVIDING NUCLEIC ACID SEQUENCING
TABLE 66 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR NUCLEIC ACID SEQUENCING, BY REGION, 2023–2030 (THOUSAND UNITS)
TABLE 67 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR NUCLEIC ACID SEQUENCING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 68 KEY PLAYERS PROVIDING MICROARRAYS
TABLE 69 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MICROARRAYS, BY REGION, 2023–2030 (THOUSAND UNITS)
TABLE 70 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MICROARRAYS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 71 KEY PLAYERS PROVIDING OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES
TABLE 72 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 73 KEY PLAYERS PROVIDING OTHER TECHNOLOGIES
TABLE 74 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 75 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 76 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR COMPANION ANIMALS
TABLE 77 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 78 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 79 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR DOGS
TABLE 80 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR DOGS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 81 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR CATS
TABLE 82 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR CATS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 83 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR HORSES
TABLE 84 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR HORSES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 85 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR OTHER COMPANION ANIMALS
TABLE 86 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 87 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 88 KEY PLAYERS PROVIDING IMMUNODIAGNOSTIC TECHNOLOGIES FOR COMPANION ANIMALS
TABLE 89 COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 90 COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 91 KEY PLAYERS PROVIDING LATERAL FLOW ASSAYS FOR COMPANION ANIMALS
TABLE 92 COMPANION ANIMALS MARKET FOR LATERAL FLOW ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 93 KEY PLAYERS PROVIDING ELISA TESTS FOR COMPANION ANIMALS
TABLE 94 COMPANION ANIMALS MARKET FOR ELISA TESTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 95 KEY PLAYERS PROVIDING IMMUNOASSAY ANALYZERS FOR COMPANION ANIMALS
TABLE 96 COMPANION ANIMALS MARKET FOR IMMUNOASSAY ANALYZERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 97 KEY PLAYERS PROVIDING OTHER IMMUNODIAGNOSTIC TECHNOLOGIES FOR COMPANION ANIMALS
TABLE 98 COMPANION ANIMALS MARKET FOR OTHER IMMUNODIAGNOSTIC TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 99 KEY PLAYERS PROVIDING MOLECULAR DIAGNOSTICS FOR COMPANION ANIMALS
TABLE 100 COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 101 COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 102 KEY PLAYERS PROVIDING PCR TESTS FOR COMPANION ANIMALS
TABLE 103 COMPANION ANIMALS MARKET FOR PCR TESTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 104 KEY PLAYERS PROVIDING NUCLEIC ACID SEQUENCING FOR COMPANION ANIMALS
TABLE 105 COMPANION ANIMALS MARKET FOR NUCLEIC ACID SEQUENCING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 106 KEY PLAYERS PROVIDING MICROARRAYS FOR COMPANION ANIMALS
TABLE 107 COMPANION ANIMALS MARKET FOR MICROARRAYS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 108 KEY PLAYERS PROVIDING OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES FOR COMPANION ANIMALS
TABLE 109 COMPANION ANIMALS MARKET FOR OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 110 KEY PLAYERS PROVIDING OTHER TECHNOLOGIES FOR COMPANION ANIMALS
TABLE 111 COMPANION ANIMALS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 112 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR LIVESTOCK
TABLE 113 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 114 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 115 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR CATTLE
TABLE 116 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR CATTLE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 117 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR PIGS
TABLE 118 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR PIGS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 119 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR POULTRY
TABLE 120 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR POULTRY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 121 KEY PLAYERS PROVIDING VETERINARY DIAGNOSTIC TESTS FOR OTHER LIVESTOCK ANIMALS
TABLE 122 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER LIVESTOCK, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 123 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 124 KEY PLAYERS PROVIDING IMMUNODIAGNOSTIC TECHNOLOGIES FOR LIVESTOCK
TABLE 125 LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 126 LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 127 KEY PLAYERS PROVIDING LATERAL FLOW ASSAYS FOR LIVESTOCK
TABLE 128 LIVESTOCK MARKET FOR LATERAL FLOW ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 129 KEY PLAYERS PROVIDING ELISA TESTS FOR LIVESTOCK
TABLE 130 LIVESTOCK MARKET FOR ELISA TESTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 131 KEY PLAYERS PROVIDING IMMUNOASSAY ANALYZERS FOR LIVESTOCK
TABLE 132 LIVESTOCK MARKET FOR IMMUNOASSAY ANALYZERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 133 KEY PLAYERS PROVIDING OTHER IMMUNODIAGNOSTIC TECHNOLOGIES FOR LIVESTOCK
TABLE 134 LIVESTOCK MARKET FOR OTHER IMMUNODIAGNOSTIC TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 135 KEY PLAYERS PROVIDING MOLECULAR DIAGNOSTICS FOR LIVESTOCK
TABLE 136 LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 137 LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 138 KEY PLAYERS PROVIDING PCR TESTS FOR LIVESTOCK
TABLE 139 LIVESTOCK MARKET FOR PCR TESTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 140 KEY PLAYERS PROVIDING NUCLEIC ACID SEQUENCING FOR LIVESTOCK
TABLE 141 LIVESTOCK MARKET FOR NUCLEIC ACID SEQUENCING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 142 KEY PLAYERS PROVIDING MICROARRAYS FOR LIVESTOCK
TABLE 143 LIVESTOCK MARKET FOR MICROARRAYS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 144 KEY PLAYERS PROVIDING OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES FOR LIVESTOCK
TABLE 145 LIVESTOCK MARKET FOR OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 146 KEY PLAYERS PROVIDING OTHER TECHNOLOGIES FOR LIVESTOCK
TABLE 147 LIVESTOCK MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 148 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 149 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR VETERINARY REFERENCE LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 150 BASIC ANNUAL EXPENSES FOR CATS & DOGS IN US, 2023 (USD)
TABLE 151 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 152 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR POC/IN-HOUSE TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 153 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR VETERINARY RESEARCH INSTITUTES & UNIVERSITIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 154 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 155 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 156 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 157 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 158 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 159 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 160 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 161 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 162 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 163 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 164 NORTH AMERICA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 165 NORTH AMERICA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 166 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 167 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 168 NORTH AMERICA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 169 NORTH AMERICA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 170 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 171 US: KEY MACROINDICATORS
TABLE 172 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 173 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 174 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 175 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 176 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 177 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 178 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 179 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 180 US: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 181 US: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 182 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 183 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 184 US: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 185 US: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 186 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 187 CANADA: KEY MACROINDICATORS
TABLE 188 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 189 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 190 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 191 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 192 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 193 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 194 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 195 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 196 CANADA: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 197 CANADA: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 198 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 199 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 200 CANADA: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 201 CANADA: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 202 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 203 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 204 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 205 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 206 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 207 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 208 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 209 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 210 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 211 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 212 EUROPE: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 213 EUROPE: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 214 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 215 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 216 EUROPE: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 217 EUROPE: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 218 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 219 GERMANY: KEY MACROINDICATORS
TABLE 220 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 221 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 222 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 223 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 224 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 225 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 226 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 227 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 228 GERMANY: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 229 GERMANY: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 230 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 231 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 232 GERMANY: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 233 GERMANY: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 234 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 235 UK: KEY MACROINDICATORS
TABLE 236 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 237 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 238 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 239 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 240 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 241 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 242 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 243 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 244 UK: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 245 UK: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 246 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 247 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 248 UK: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 249 UK: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 250 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 251 FRANCE: KEY MACROINDICATORS
TABLE 252 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 253 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 254 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 255 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 256 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 257 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 258 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 259 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 260 FRANCE: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 261 FRANCE: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 262 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 263 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 264 FRANCE: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 265 FRANCE: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 266 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 267 ITALY: KEY MACROINDICATORS
TABLE 268 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 269 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 270 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 271 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 272 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 273 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 274 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 275 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 276 ITALY: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 277 ITALY: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 278 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 279 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 280 ITALY: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 281 ITALY: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 282 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 283 SPAIN: KEY MACROINDICATORS
TABLE 284 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 285 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 286 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 287 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 288 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 289 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 290 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 291 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 292 SPAIN: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 293 SPAIN: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 294 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 295 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 296 SPAIN: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 297 SPAIN: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 298 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 299 NETHERLANDS: KEY MACROINDICATORS
TABLE 300 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 301 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 302 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 303 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 304 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 305 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 306 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 307 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 308 NETHERLANDS: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 309 NETHERLANDS: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 310 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 311 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 312 NETHERLANDS: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 313 NETHERLANDS: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 314 NETHERLANDS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 315 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 316 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 317 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 318 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 319 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 320 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)
TABLE 321 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 322 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 323 REST OF EUROPE: COMPANION ANIMALS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 324 REST OF EUROPE: COMPANION ANIMALS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 325 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2023–2030 (USD MILLION)
TABLE 326 REST OF EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 327 REST OF EUROPE: LIVESTOCK MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 328 REST OF EUROPE: LIVESTOCK MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TAB
LIST OF FIGURES
FIGURE 1 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SEGMENTATION & REGIONAL SCOPE
FIGURE 2 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: RESEARCH DESIGN
FIGURE 3 PRIMARY SOURCES
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION (SUPPLY SIDE)
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY END USER, DESIGNATION, AND REGION (DEMAND SIDE)
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: IDEXX LABORATORIES, INC.
FIGURE 9 REVENUE ANALYSIS OF TOP FIVE COMPANIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET (2024)
FIGURE 10 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: DEMAND-SIDE ANALYSIS
FIGURE 11 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET (2025–2030)
FIGURE 12 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 13 TOP-DOWN APPROACH
FIGURE 14 BOTTOM-UP APPROACH
FIGURE 15 MARKET DATA TRIANGULATION METHODOLOGY
FIGURE 16 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
FIGURE 17 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)
FIGURE 18 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 19 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 20 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)
FIGURE 21 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 22 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)
FIGURE 23 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
FIGURE 24 GEOGRAPHIC SNAPSHOT OF VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET
FIGURE 25 INCREASING INCIDENCE OF INFECTIOUS DISEASES TO FUEL MARKET GROWTH
FIGURE 26 CONSUMABLES SEGMENT AND CHINA ACCOUNTED FOR LARGEST MARKET SHARES IN 2024
FIGURE 27 ASIA PACIFIC REGION TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 28 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
FIGURE 29 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
FIGURE 30 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 31 EUROPE: PET POPULATION, 2021–2023
FIGURE 32 US: PET EXPENDITURE, DOGS VS. CATS, 2024 (USD)
FIGURE 33 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 34 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: NUMBER OF GRANTED PATENT APPLICATIONS (JANUARY 2014–MAY 2025)
FIGURE 35 TOP APPLICANT COUNTRIES/REGIONS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS PATENTS (JANUARY 2014–MAY 2025)
FIGURE 36 AVERAGE SELLING PRICE TREND FOR ELISA TEST KITS AND PCR TEST KITS, BY KEY PLAYER, 2024
FIGURE 37 AVERAGE SELLING PRICE OF ELISA AND PCR TEST KITS, BY REGION, 2024
FIGURE 38 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTIC PRODUCTS
FIGURE 39 KEY BUYING CRITERIA FOR TOP THREE END USERS
FIGURE 40 AI USE CASES
FIGURE 41 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: ECOSYSTEM MARKET MAP
FIGURE 42 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: VALUE CHAIN ANALYSIS
FIGURE 43 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 44 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: ADJACENT MARKETS
FIGURE 45 INVESTMENT AND FUNDING SCENARIO FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET PLAYERS, 2020–2024
FIGURE 46 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: GEOGRAPHIC SNAPSHOT
FIGURE 47 EXPECTED GROWTH IN NUMBER OF VETERINARIANS IN NORTH AMERICA, 2012–2030
FIGURE 48 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SNAPSHOT
FIGURE 49 ASIA PACIFIC: DOG POPULATION GROWTH, BY COUNTRY, 2024
FIGURE 50 ASIA PACIFIC: CAT POPULATION GROWTH, BY COUNTRY, 2024
FIGURE 51 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SNAPSHOT
FIGURE 52 REVENUE ANALYSIS OF KEY PLAYERS IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET (2020–2024)
FIGURE 53 MARKET SHARE ANALYSIS OF KEY PLAYERS IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS (2024)
FIGURE 54 MARKET SHARE ANALYSIS OF KEY PLAYERS IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK (2024)
FIGURE 55 RANKING OF KEY PLAYERS IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, 2024
FIGURE 56 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 57 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: COMPANY FOOTPRINT
FIGURE 58 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
FIGURE 59 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 60 R&D EXPENDITURE OF KEY PLAYERS IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, 2022–2024
FIGURE 61 EV/EBITDA OF KEY VENDORS
FIGURE 62 YEAR-TO-DATE (YTD) PRICE OF TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 63 IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT (2024)
FIGURE 64 ZOETIS SERVICES LLC: COMPANY SNAPSHOT (2024)
FIGURE 65 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024)
FIGURE 66 VIRBAC: COMPANY SNAPSHOT (2024)
FIGURE 67 BIOM?RIEUX: COMPANY SNAPSHOT (2024)
FIGURE 68 NEOGEN CORPORATION: COMPANY SNAPSHOT (2024)
FIGURE 69 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024)
FIGURE 1 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SEGMENTATION & REGIONAL SCOPE
FIGURE 2 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: RESEARCH DESIGN
FIGURE 3 PRIMARY SOURCES
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION (SUPPLY SIDE)
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY END USER, DESIGNATION, AND REGION (DEMAND SIDE)
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: IDEXX LABORATORIES, INC.
FIGURE 9 REVENUE ANALYSIS OF TOP FIVE COMPANIES: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET (2024)
FIGURE 10 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: DEMAND-SIDE ANALYSIS
FIGURE 11 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET (2025–2030)
FIGURE 12 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 13 TOP-DOWN APPROACH
FIGURE 14 BOTTOM-UP APPROACH
FIGURE 15 MARKET DATA TRIANGULATION METHODOLOGY
FIGURE 16 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
FIGURE 17 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)
FIGURE 18 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 19 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 20 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)
FIGURE 21 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 22 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)
FIGURE 23 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
FIGURE 24 GEOGRAPHIC SNAPSHOT OF VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET
FIGURE 25 INCREASING INCIDENCE OF INFECTIOUS DISEASES TO FUEL MARKET GROWTH
FIGURE 26 CONSUMABLES SEGMENT AND CHINA ACCOUNTED FOR LARGEST MARKET SHARES IN 2024
FIGURE 27 ASIA PACIFIC REGION TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 28 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
FIGURE 29 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
FIGURE 30 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 31 EUROPE: PET POPULATION, 2021–2023
FIGURE 32 US: PET EXPENDITURE, DOGS VS. CATS, 2024 (USD)
FIGURE 33 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 34 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: NUMBER OF GRANTED PATENT APPLICATIONS (JANUARY 2014–MAY 2025)
FIGURE 35 TOP APPLICANT COUNTRIES/REGIONS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS PATENTS (JANUARY 2014–MAY 2025)
FIGURE 36 AVERAGE SELLING PRICE TREND FOR ELISA TEST KITS AND PCR TEST KITS, BY KEY PLAYER, 2024
FIGURE 37 AVERAGE SELLING PRICE OF ELISA AND PCR TEST KITS, BY REGION, 2024
FIGURE 38 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTIC PRODUCTS
FIGURE 39 KEY BUYING CRITERIA FOR TOP THREE END USERS
FIGURE 40 AI USE CASES
FIGURE 41 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: ECOSYSTEM MARKET MAP
FIGURE 42 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: VALUE CHAIN ANALYSIS
FIGURE 43 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 44 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: ADJACENT MARKETS
FIGURE 45 INVESTMENT AND FUNDING SCENARIO FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET PLAYERS, 2020–2024
FIGURE 46 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: GEOGRAPHIC SNAPSHOT
FIGURE 47 EXPECTED GROWTH IN NUMBER OF VETERINARIANS IN NORTH AMERICA, 2012–2030
FIGURE 48 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SNAPSHOT
FIGURE 49 ASIA PACIFIC: DOG POPULATION GROWTH, BY COUNTRY, 2024
FIGURE 50 ASIA PACIFIC: CAT POPULATION GROWTH, BY COUNTRY, 2024
FIGURE 51 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SNAPSHOT
FIGURE 52 REVENUE ANALYSIS OF KEY PLAYERS IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET (2020–2024)
FIGURE 53 MARKET SHARE ANALYSIS OF KEY PLAYERS IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS (2024)
FIGURE 54 MARKET SHARE ANALYSIS OF KEY PLAYERS IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR LIVESTOCK (2024)
FIGURE 55 RANKING OF KEY PLAYERS IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, 2024
FIGURE 56 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 57 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: COMPANY FOOTPRINT
FIGURE 58 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
FIGURE 59 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 60 R&D EXPENDITURE OF KEY PLAYERS IN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, 2022–2024
FIGURE 61 EV/EBITDA OF KEY VENDORS
FIGURE 62 YEAR-TO-DATE (YTD) PRICE OF TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 63 IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT (2024)
FIGURE 64 ZOETIS SERVICES LLC: COMPANY SNAPSHOT (2024)
FIGURE 65 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024)
FIGURE 66 VIRBAC: COMPANY SNAPSHOT (2024)
FIGURE 67 BIOM?RIEUX: COMPANY SNAPSHOT (2024)
FIGURE 68 NEOGEN CORPORATION: COMPANY SNAPSHOT (2024)
FIGURE 69 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024)
